Near Infrared Spectroscopy for Single Ventricle Heart
Trial Summary
What is the purpose of this trial?
The purpose of this study is to assess the utility of renal near infrared spectroscopy in the outpatient setting during the interstage period. The primary aim will be to determine the correlation between oxygen extraction ratio ((arterial pulse oximetry - renal near infrared spectroscopy value)/arterial pulse oximetry value) with need for inpatient admission or intervention. Secondary aims will be to determine the correlation of the oxygen extraction ratio with weight gain, neurodevelopment, unexpected admissions, systemic ventricular strain by echocardiography, and Glenn hospitalization admission characteristics.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What data supports the effectiveness of the treatment Near Infrared Spectroscopy for Single Ventricle Heart?
Is Near Infrared Spectroscopy (NIRS) safe for use in humans?
Near Infrared Spectroscopy (NIRS) is generally considered safe as it is a noninvasive method used to monitor tissue oxygenation. However, studies have shown that during procedures, some patients experienced adverse events like desaturation and arrhythmia, which were detected by NIRS. It is important to note that these events were related to the medical procedures rather than the use of NIRS itself.678910
How does near-infrared spectroscopy treatment differ from other treatments for single ventricle heart conditions?
Near-infrared spectroscopy (NIRS) is unique because it is a non-invasive method that continuously monitors regional tissue oxygenation, allowing real-time assessment of oxygen supply and demand in the body. Unlike other treatments that may focus on direct intervention, NIRS provides valuable information on how well oxygen is being delivered to tissues, which can be crucial for managing patients with single ventricle heart conditions.411121314
Research Team
Joshua Wong, MD
Principal Investigator
Advocate Children's Hospital
Eligibility Criteria
This trial is for individuals with a heart condition known as Single Ventricle Heart. It's specifically looking at patients in the interstage period, which is the time between their first and second heart surgeries.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Interstage Monitoring
Participants have renal near infrared spectroscopy recorded in clinic to assess oxygen extraction ratio and its correlation with clinical outcomes
Follow-up
Participants are monitored for safety and effectiveness after the interstage monitoring period
Treatment Details
Interventions
- Near Infrared Spectroscopy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Advocate Hospital System
Lead Sponsor